You have reached an outdated page.
Please visit the Defeat Diabetes Foundation's new Web site at:
http://www.DefeatDiabetes.org
Defeat Diabetes: FDA Issues Nationwide Alert for "Liqiang 4" Due to Potential Health Risk

Home

About Diabetes

Complications

Warning Signs

Screening Test

Donate Now

E-Lerts
Index

Latest News

Diabetes Terms

Health & Fitness

Online Press Center

Meet Mr. Diabetes®

Wake Up And Walk® Tour

Support Groups

Headlines & Stories

About Us - Contact Info

Links

 

FDA Issues Nationwide Alert for "Liqiang 4" Due to Potential Health Risk
posted July 22, 2005

Warning consumers not to take Liqiang 4 Dietary Supplement Capsules because they contain glyburide – a drug that could have serious, life-threatening consequences in some people.

Glyburide is a drug used to lower blood sugar, and is safe and effective when used as labeled in FDA-approved medications. People who have low blood sugar or those with diabetes can receive dangerously high amounts of glyburide by consuming Liqiang 4. Consumers should immediately stop using these products and seek medical attention, especially if they are currently being treated with diabetes drugs or if they have symptoms of fatigue, excessive hunger, profuse sweating, or numbness of the extremities. Consumers who have this product should dispose of it immediately.

The product is sold as part of a shrink-wrapped two bottle set. The product is manufactured by Liqiang Research Institute, China, and marketed throughout the United States in herbal stores and through mail order by Bugle International of Northridge CA.

The FDA learned of the potential problem through an anonymous consumer complaint and followed up with testing that revealed the presence of glyburide in this product.

The product has also been termed "Liqiang Xiao Ke Ling" (Liqiang Thirst Quenching Efficacious) in ads in Chinese language publications which also promote it as useful for the control of diabetes and being derived from only natural ingredients.

FDA encourages consumers, health care providers, and caregivers to report any adverse events related to this product to MedWatch, the FDA's voluntary reporting program at 1-800-FDA-1088; by FAX at 1-800-FDA-0178; by mail to MedWatch, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD, 20857-9787; or online at www.fda.gov/medwatch/report.htm.

Source: Diabetes In Control.com.

News Article Index

Free Diabetes E-Lerts™ Newsletter:  Subscribe


   
To Change, Or Even Help Save The Lives Of Millions Of People,
Consider Making a Donation to Defeat Diabetes Foundation - Thank You! 

Home - About Diabetes - Complications - Warning Signs - Screening Test - Donate Now - Special Events - Latest News - Health & Fitness - Online Press Center - E-Lerts Index - Meet Mr. Diabetes® - Wake Up And Walk® Tour - About Us - Diabetes Terms - Site SearchYour Diabetes Profile Privacy Policy - Legal Notices - How to Contact Us - Comments form - Suggestion Form - Our E-Mail Addresses - Our Address and Phone Numbers - Links - Contact Us

To be sure and come back to keep up with all the Latest News and important information for diabetics - and to remind yourself to manage and control your diabetes, click the yellow link below to add a small icon of our Defeat Diabetes® "Torch" logo to your desktop.  All you need to do after that is click on the "Torch" to open our website.  Remember, we're here for you!Add Us To Your Desktop! 

                                                                                                               

      We subscribe to the HONcode principles of the HON Foundation. Click to verify.We subscribe to the HONcode principles of the Health On the Net Foundation
Date of last update:  07/23/05
To contact Webmaster: webmaster@defeatdiabetes.org 

Translate this page into Spanish using FreeTranslation.com.

 © Copyright 2001 - 2004, Defeat Diabetes Foundation, Inc., All Rights Reserved